Brief: Adagio Medical Submits Premarket Approval Application To FDA For Vclas® Ventricular Ablation System
21/05/2026 13:30
May 21 (Reuters) - Adagio Medical Holdings Inc ADGM.O: ADAGIO MEDICAL SUBMITS PREMARKET APPROVAL APPLICATION TO FDA FOR VCLAS® VENTRICULAR ABLATION SYSTEM FOR THE TREATMENT OF VENTRICULAR TACHYCARDIA Source text: ID:nBw4CS3dQa Further company coverage: ADGM.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Adagio Medical Holdings
See all newsBrief: Adagio Medical Submits Premarket Approval Application To FDA For Vclas® Ventricular Ablation System
Brief: Adagio Medical Announces Positive Pivotal Results For vCLAS Ventricular Ablation System
U.S. RESEARCH ROUNDUP-Biogen, Equinix, Revolution Medicines
U.S. STOCKS ON THE MOVE-Meta, Legence, Chegg
Adagio Medical rises after FDA clears expanded testing of heart device